Both ANP and BNP are effective for detecting left ventricular dysfunction, with BNP showing superior sensitivity for identifying patients with weakened heart pumping before obvious symptoms develop.
Pre-symptomatic detectionBNP identifies left ventricular dysfunction before patients develop obvious heart failure symptoms
What the researchers found
BNP demonstrates superior sensitivity over ANP for detecting subclinical left ventricular dysfunction, supporting its use as a screening tool for early identification of heart failure risk.
Why it matters
Many people have weakened hearts without knowing it. A simple blood test that catches this early allows treatment before irreversible damage occurs, potentially preventing heart failure.
How the study worked
Review of clinical studies evaluating ANP and BNP as biomarkers for left ventricular dysfunction screening, diagnosis, and prognosis assessment.
What this study cannot tell us
Review based on available studies through 1999. Optimal cutoff values and screening protocols were still being refined. Cost-effectiveness of population screening not established.
How to read the evidence
Strong evidence from a review of multiple clinical studies consistently showing BNP's screening and diagnostic value for LV dysfunction.
When this study was published
Published in 1999. BNP and NT-proBNP testing are now standard worldwide for heart failure diagnosis and screening.
The bigger picture
Heart failure prevention depends on early detection. Natriuretic peptide testing represents one of the most important advances in cardiovascular screening, enabling identification of at-risk patients through a simple blood draw.
Questions still open
- Should routine health checkups include BNP screening?
- What BNP cutoff optimally balances sensitivity and specificity?
- Can serial BNP testing track the transition from normal to impaired heart function?
Common questions
Can a blood test detect heart problems?
Should everyone get tested?
Read the original research
Natriuretic peptides in assessment of left-ventricular dysfunction.
Scandinavian journal of clinical and laboratory investigation. Supplementum, 230, 132-42
Citation
Mair, J; Friedl, W; Thomas, S; Puschendorf, B. (1999). Natriuretic peptides in assessment of left-ventricular dysfunction.. Scandinavian journal of clinical and laboratory investigation. Supplementum, 230, 132-42.